Bionime : Announcement of the company's 2022 annual meeting of shareholders to comprehensively re-elected directors (including independent directors) elected list.

Close

Today's Information

Provided by: BIONIME CORPORATION
SEQ_NO	2	Date of announcement	2022/06/22	Time of announcement	18:29:44
Subject	Announcement of the company's 2022 annual meeting of shareholders to comprehensively re-elected directors (including independent directors) elected list.
Date of events	2022/06/22	To which item it meets	paragraph 6
Statement	1.Date of occurrence of the change:2022/06/22 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor):institutional director,independent director, natural-person director 3.Title and name of the previous position holder: Director:Huang,Chun-Mu Director:HUA ENG WIRE&CABLE CO., LTD. Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Director:Chiang,Tai-Hsiung Independent Director:Tsai ,Gan-Ren Independent Director:Kuo, Li-Jen Independent Director:Lu,Hsueh-Yu 4.Resume of the previous position holder: Director:Huang,Chun-Mu/Chairman and General Manager of Bionime Corporation. Director:HUA ENG WIRE&CABLE CO., LTD./Accounting Manager at HUA ENG WIRE&CABLE CO., LTD Director:TONGHUA DONGBAO Pharmaceutical CO., LTD./Director at Bionime Corporation Director:Chiang,Tai-Hsiung/Director at Bionime Corporation Independent Director:Tsai ,Gan-Ren/Professor f Department of Medical Laboratory and Biotechnology, Chung Shan Medical University Independent Director:Kuo, Li-Jen/Independent Director of Sunnic Technology & Merchandise Inc. Independent Director:Lu,Hsueh-Yu/General Manager of VEGA TECHNOLOGIES INC. 5.Title and name of the new position holder: Director:Huang,Chun-Mu Director:HUA ENG WIRE&CABLE CO., LTD Representative： Liou, Xiu-Mei Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Representative: Leng,Chun-Sheng Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Representative: Zhang Wen-Hai Director:Yanben Investment Co., Ltd. Director:Baijue Investment Co., Ltd. Independent Director:Zeng,Hui-Jin Independent Director:Liu,Mei-An Independent Director:Chen,Rui-Xin 6.Resume of the new position holder: Director:Huang,Chun-Mu/Chairman and General Manager of Bionime Corporation. Director:HUA ENG WIRE&CABLE CO., LTD Representative： Liou, Xiu-Mei/ Accounting Manager at HUA ENG WIRE&CABLE CO., LTD. Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Representative: Leng,Chun-Sheng/Chairman and General Manager of TONGHUA DONGBAO Pharmaceutical CO. Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Representative: Zhang Wen-Hai/Deputy General Manager of TONGHUA DONGBAO Pharmaceutical CO. Director:Yanben Investment Co., Ltd./Corporate Director at Advantech Co., Ltd. Director:Baijue Investment Co., Ltd. Independent Director:Zeng,Hui-Jin/Partner, Deputy Director, Chief Operating Officer, Chief Strategy Officer of PricewaterhouseCoopers Taiwan Independent Director:Liu,Mei-An/Deputy General Manager of FUBON FINANCIAL HOLDING VENTURE CAPITAL CORPORATION Independent Director:Chen,Rui-Xin/Former Deputy Director at the Trademark Division, Bureau of Standards, Metrology and Inspection, MOEA. 7.Circumstances of change (Please enter "resignation", "dismissal", "term expired", "death" or "new appointment"):Term expired 8.Reason for the change:Term expired to comprehensively re-elected directors 9.Number of shares held by the new position holder when elected: Director:Huang,Chun-Mu/2,474,492 Shareholdings Director:HUA ENG WIRE&CABLE CO., LTD Representative： Liou, Xiu-Mei/7,807,900 Shareholdings Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Representative: Leng,Chun-Sheng/12,000,000 Shareholdings Director:TONGHUA DONGBAO Pharmaceutical CO., LTD. Representative: Zhang Wen-Hai//12,000,000 Shareholdings Director:Yanben Investment Co., Ltd./1,500,000 Shareholdings Director:Baijue Investment Co., Ltd./18,000 Shareholdings Independent Director:Zeng,Hui-Jin/0 Shareholdings Independent Director:Liu,Mei-An/96,171 Shareholdings Independent Director:Chen,Rui-Xin/20,000 Shareholdings 10.Original term (from __________ to __________):2019/06/20~2022/06/20 11.Effective date of the new appointment:2022/06/22~2025/06/21 12.Turnover rate of directors of the same term:N/A 13.Turnover rate of independent directors of the same term:N/A 14.Turnover rate of supervisors of the same term:N/A 15.Change in one-third or more of directors (Please enter "Yes" or "No"):YES (Tear expired) 16.Any other matters that need to be specified:NONE.